asparagine has been researched along with HIV Coinfection in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Furusho, A; Hamase, K; Ishii, C; Kamarulzaman, A; Kamaruzzaman, SB; Lee, CS; Leong, KH; Mita, M; Rajasuriar, R; Shaharudin, S; Yap, SH; Zulhaimi, NS | 1 |
| Chen, CY; Chen, KB; Hung, TC; Lee, WY | 1 |
| Aboulker, JP; Bentata, M; Brun-Vézinet, F; Capitant, C; Chazallon, C; Descamps, D; Katlama, C; Landman, R; Peytavin, G; Pialoux, G; Yéni, P | 1 |
| Huang, W; Lewis, ST; Petropoulos, CJ; Stawiski, E; Toma, J; Weinheimer, SP; Whitcomb, JM | 1 |
| Hensel, M; McCaffrey, RA; Saunders, C; Stamatatos, L | 1 |
| Akinsete, O; Cartwright, C; Henry, K; Hirigoyen, D; Kantor, R; Schut, R | 1 |
| Griffin, GE; Hu, Q; Napier, KB; Peiper, SC; Shattock, RJ; Taylor, S; Trent, JO; Wang, Z | 1 |
| Conway, JA; Hughes, SH; Kappes, JC; Mulky, A; Vu, BC | 1 |
| Parris, GE | 1 |
| Grange, JM; Hamedi-Sangsari, F; Malley, SD; Vila, JR | 1 |
| Hamedi-Sangsari, F; Lockhart, BP; Privat, A; Vignon, J; Vila, J | 1 |
| Ly, A; Stamatatos, L | 1 |
1 trial(s) available for asparagine and HIV Coinfection
| Article | Year |
|---|---|
Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asparagine; Atazanavir Sulfate; Carbamates; CD4 Lymphocyte Count; Female; Furans; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Oligopeptides; Organophosphates; Pyridines; Quinolines; Ritonavir; RNA, Viral; Sulfonamides; Treatment Outcome; Viral Load | 2009 |
11 other study(ies) available for asparagine and HIV Coinfection
| Article | Year |
|---|---|
Plasma d-amino acids are associated with markers of immune activation and organ dysfunction in people with HIV.
Topics: Alanine; Amino Acids; Asparagine; Biomarkers; HIV Infections; Humans; Multiple Organ Failure; Proline; Serine | 2022 |
Lead screening for CXCR4 of the human HIV infection receptor inhibited by traditional Chinese medicine.
Topics: Asparagine; HIV Infections; HIV-1; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Medicine, Chinese Traditional; Molecular Docking Simulation; Molecular Dynamics Simulation; Receptors, CCR5; Receptors, CXCR4; Receptors, HIV | 2014 |
Loss of asparagine-linked glycosylation sites in variable region 5 of human immunodeficiency virus type 1 envelope is associated with resistance to CD4 antibody ibalizumab.
Topics: Amino Acid Sequence; Anti-HIV Agents; Antibodies; Antibodies, Monoclonal; Asparagine; Clinical Trials as Topic; DNA Mutational Analysis; Drug Resistance, Viral; Glycosylation; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation, Missense; Myoviridae; Sequence Analysis, DNA | 2011 |
N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.
Topics: Amino Acid Sequence; Antibodies, Monoclonal; Asparagine; Cells, Cultured; Glycosylation; HIV Antibodies; HIV Envelope Protein gp120; HIV Envelope Protein gp41; HIV Infections; HIV-1; Humans; Immune Sera; Kinetics; Molecular Sequence Data; Neutralization Tests; Receptors, HIV; Virion; Virus Replication | 2004 |
K103N mutation in antiretroviral therapy-naive African patients infected with HIV type 1.
Topics: Amino Acid Substitution; Antiretroviral Therapy, Highly Active; Asparagine; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lysine; Male; Middle Aged; Mutation, Missense; RNA-Directed DNA Polymerase; Viral Proteins | 2004 |
Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization.
Topics: Amino Acid Sequence; Asparagine; Aspartic Acid; CD4-Positive T-Lymphocytes; Chemokine CCL5; Gene Products, env; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Molecular Sequence Data; Mutation; Proline; Protein Structure, Tertiary; Receptors, CCR5 | 2005 |
Analysis of amino acids in the beta7-beta8 loop of human immunodeficiency virus type 1 reverse transcriptase for their role in virus replication.
Topics: Alanine; Amino Acid Sequence; Amino Acids; Asparagine; Dimerization; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Inhibitory Concentration 50; Molecular Sequence Data; Mutation; Protein Binding; Protein Structure, Secondary; Protein Subunits; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virion; Virus Replication | 2007 |
2-deoxy-D-glucose as a potential drug against fusogenic viruses including HIV.
Topics: Animals; Antiviral Agents; Asparagine; Carbohydrates; Cell Fusion; Deoxyglucose; Drug Resistance, Viral; Glycolysis; Glycosylation; HIV Fusion Inhibitors; HIV Infections; Humans; Models, Biological; Models, Theoretical; Viral Envelope Proteins | 2008 |
Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.
Topics: Antiviral Agents; Asparagine; Aspartic Acid; Cell Survival; Cells, Cultured; Didanosine; Drug Synergism; HIV Infections; Humans; Hydroxyurea; In Vitro Techniques; Lymphocyte Activation; Lymphocytes; Virus Replication; Zalcitabine; Zidovudine | 1994 |
Neurotoxic effect of the anti-HIV drug D-aspartate beta-hydroxamate for rat primary neuronal cultures: attenuation by N-methyl-D-aspartate (NMDA) antagonists.
Topics: Animals; Asparagine; Cells, Cultured; Cerebral Cortex; HIV Infections; N-Methylaspartate; Neurons; Rats; Rats, Sprague-Dawley | 1993 |
V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
Topics: Amino Acid Sequence; Asparagine; Binding Sites, Antibody; CD4 Antigens; Glycosylation; HeLa Cells; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Macrophages; Molecular Sequence Data; Neutralization Tests; Peptide Fragments; Phenotype; Receptors, CCR5; Viral Envelope Proteins; Virus Replication | 2000 |